{"companyId":285095,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"ティジアナ・ライフサイエンス株式会社","headOfficeLocation":"ロンドン、コンジットストリート14/15、W1S 2XJ、イギリス","presidentName":"アイヴァー・エルリフィ","companySummary":null,"stockCode":"TLSA","currency":"USD","capital":null,"sales":null,"employees":10,"employeesConsolidated":null,"humanCheck":false,"domains":["tizianalifesciences.com"],"businessContents":["バイオ医薬品の開発","神経変性疾患の免疫療法"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://tizianalifesciences.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}